Evuzamitide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Evuzamitide, covering 2025-07-18 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels